Search research articles
Contact Us
Filters
Showing results (131-140 of 421) with videos related to
Page
of 43
Sort By:
Journal for Immunotherapy of Cancer
|
August 30, 2019
A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
Yiyin Zhang, Jin Xu, Jie Hua, et al.
World Journal of Surgical Oncology
|
August 8, 2019
AJCC 7th edition staging classification is more applicable than AJCC 8th edition staging classification for invasive IPMN
Zhiyao Fan, He Cheng, Kaizhou Jin, et al.
Oncology Letters
|
May 20, 2017
Clinical outcomes and prognostic factors of resected pancreatic neuroendocrine neoplasms: A single-center experience in China
Kaizhou Jin, Guopei Luo, Jin Xu, et al.
Cancers
|
December 18, 2019
Role of Damage DNA-Binding Protein 1 in Pancreatic Cancer Progression and Chemoresistance
Yiyin Zhang, Yubin Lei, Jin Xu, et al.
Cell Death & Disease
|
August 26, 2024
NLRP4 renders pancreatic cancer resistant to olaparib through promotion of the DNA damage response and ROS-induced autophagy
Mingming Xiao, Jing Yang, Mingwei Dong, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
April 7, 2020
Prior history of acute pancreatitis predicts poor survival in patients with resectable pancreatic ductal adenocarcinoma
Yitao Gong, Zhiyao Fan, Guopei Luo, et al.
Annals of Surgical Oncology
|
September 22, 2016
Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer
Zuqiang Liu, Kaizhou Jin, Meng Guo, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
September 26, 2016
The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients
He Cheng, Guopei Luo, Yu Lu, et al.
Experimental & Molecular Medicine
|
April 4, 2018
Complex roles of the stroma in the intrinsic resistance to gemcitabine in pancreatic cancer: where we are and where we are going
Chen Liang, Si Shi, Qingcai Meng, et al.
BMC Cancer
|
July 21, 2022
Comprehensive analysis of the prognosis and immune infiltration landscape of RNA methylation-related subtypes in pancreatic cancer
Siyuan Lu, Jie Hua, Jiang Liu, et al.
Page
of 43
Search research articles
Search
Showing results (131-140 of 421) with videos related to
Sort By:
Page
of 43
Journal for Immunotherapy of Cancer
|
August 30, 2019
A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
Yiyin Zhang, Jin Xu, Jie Hua, et al.
World Journal of Surgical Oncology
|
August 8, 2019
AJCC 7th edition staging classification is more applicable than AJCC 8th edition staging classification for invasive IPMN
Zhiyao Fan, He Cheng, Kaizhou Jin, et al.
Oncology Letters
|
May 20, 2017
Clinical outcomes and prognostic factors of resected pancreatic neuroendocrine neoplasms: A single-center experience in China
Kaizhou Jin, Guopei Luo, Jin Xu, et al.
Cancers
|
December 18, 2019
Role of Damage DNA-Binding Protein 1 in Pancreatic Cancer Progression and Chemoresistance
Yiyin Zhang, Yubin Lei, Jin Xu, et al.
Cell Death & Disease
|
August 26, 2024
NLRP4 renders pancreatic cancer resistant to olaparib through promotion of the DNA damage response and ROS-induced autophagy
Mingming Xiao, Jing Yang, Mingwei Dong, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
April 7, 2020
Prior history of acute pancreatitis predicts poor survival in patients with resectable pancreatic ductal adenocarcinoma
Yitao Gong, Zhiyao Fan, Guopei Luo, et al.
Annals of Surgical Oncology
|
September 22, 2016
Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer
Zuqiang Liu, Kaizhou Jin, Meng Guo, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
September 26, 2016
The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients
He Cheng, Guopei Luo, Yu Lu, et al.
Experimental & Molecular Medicine
|
April 4, 2018
Complex roles of the stroma in the intrinsic resistance to gemcitabine in pancreatic cancer: where we are and where we are going
Chen Liang, Si Shi, Qingcai Meng, et al.
BMC Cancer
|
July 21, 2022
Comprehensive analysis of the prognosis and immune infiltration landscape of RNA methylation-related subtypes in pancreatic cancer
Siyuan Lu, Jie Hua, Jiang Liu, et al.
Page
of 43